|
1
|
Pewzner-Jung Y, Ben-Dor S and Futerman AH:
When do Lasses (longevity assurance genes) become CerS (ceramide
synthases)? Insights into the regulation of ceramide synthesis. J
Biol Chem. 281:25001–25005. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang H, Wang J, Zuo Y, et al: Expression
and prognostic significance of a new tumor metastasis suppressor
gene LASS2 in human bladder carcinoma. Med Oncol. 29:1921–1927.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan S, Niu Y, Tan N, et al: LASS2 enhances
chemosensitivity of breast cancer by counteracting acidic tumor
microenvironment through inhibiting activity of V-ATPase proton
pump. Oncogene. 32:1682–1690. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Imgrund S, Hartmann D, Farwanah H, et al:
Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin
sheath defects, cerebellar degeneration, and hepatocarcinomas. J
Biol Chem. 284:33549–33560. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen L, Lu X, Zeng T, et al: Enhancement
of DEN-induced liver tumourigenesis in hepatocyte-specific
Lass2-knockout mice coincident with upregulation of the
TGF-β1-Smad4-PAI-1 axis. Oncol Rep. 31:885–893. 2014.PubMed/NCBI
|
|
6
|
Teufel A, Maass T, Galle PR, et al: The
longevity assurance homologue of yeast lag1 (Lass) gene family
(Review). Int J Mol Med. 23:135–140. 2009.PubMed/NCBI
|
|
7
|
Morad SAF and Cabot MC:
Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer.
13:51–65. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stiban J, Tidhar R and Futerman AH:
Ceramide synthases: roles in cell physiology and signaling. Adv Exp
Med Biol. 688:60–71. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saddoughi SA and Ogretmen B: Diverse
functions of ceramide in cancer cell death and proliferation. Adv
Cancer Res. 117:37–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu J, Beckman BS and Foroozesh M: A
review of ceramide analogs as potential anticancer agents. Future
Med Chem. 5:1405–1421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park JW, Park WJ, Kuperman Y, Boura-Halfon
S, Pewzner-Jung Y and Futerman AH: Ablation of very long acyl chain
sphingolipids causes hepatic insulin resistance in mice due to
altered detergent-resistant membranes. Hepatology. 57:525–532.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Silva LC, Ben David O, Pewzner-Jung Y, et
al: Ablation of ceramide synthase 2 strongly affects biophysical
properties of membranes. J Lipid Res. 53:430–436. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma A and Malynn BA: A20: linking a complex
regulator of ubiquitylation to immunity and human disease. Nat Rev
Immunol. 12:774–785. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pujari R, Hunte R, Khan W and Shembade N:
A20-mediated negative regulation of canonical NF-κB signaling
pathway. Immunol Res. 57:166–171. 2013.PubMed/NCBI
|
|
15
|
Zhang F, Yang L and Li Y: The role of A20
in the pathogenesis of lymphocytic malignancy. Cancer Cell Int.
12:442012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang M and Li S: Bladder polypoid
cystitis-derived A20 associates with tumorigenesis. Cell Biochem
Biophys. 67:669–673. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hjelmeland AB, Wu Q, Wickman S, et al:
Targeting A20 decreases glioma stem cell survival and tumor growth.
PLoS Biol. 8:e10003192010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang CM, Wang Y, Fan CG, et al: miR-29c
targets TNFAIP3, inhibits cell proliferation and induces apoptosis
in hepatitis B virus-related hepatocellular carcinoma. Biochem
Biophys Res Commun. 411:586–592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ali M, Fritsch J, Zigdon H, Pewzner-Jung
Y, Schütze S and Futerman AH: Altering the sphingolipid acyl chain
composition prevents LPS/GLN-mediated hepatic failure in mice by
disrupting TNFR1 internalization. Cell Death Dis. 4:e9292013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su Y, Li X, Ji W, et al: Small molecule
with big role: MicroRNAs in cancer metastatic microenvironments.
Cancer Lett. 344:147–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cante-Barrett K, Pieters R and Meijerink
JPP: Myocyte enhancer factor 2C in hematopoiesis and leukemia.
Oncogene. 33:403–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Higginbotham KS, Breyer JP, Bradley KM, et
al: A multistage association study identifies a breast cancer
genetic locus at NCOA7. Cancer Res. 71:3881–3888. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bronicki LM and Jasmin BJ: Emerging
complexity of the HuD/ELAVl4 gene; implications for neuronal
development, function, and dysfunction. RNA. 19:1019–1037. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee EK, Kim W, Tominaga K, et al:
RNA-binding protein HuD controls insulin translation. Mol Cell.
45:826–835. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye AA and Maresca TJ: Cell division:
kinetochores SKAdaddle. Curr Biol. 23:R122–R124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ullman KS, Shah S, Powers MA and Forbes
DJ: The nucleoporin nup153 plays a critical role in multiple types
of nuclear export. Mol Biol Cell. 10:649–664. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matsuda T, Hashimoto Y, Ueda H, et al:
Specific isoprenyl group linked to transducin gamma-subunit is a
determinant of its unique signaling properties among G-proteins.
Biochemistry. 37:9843–9850. 1998. View Article : Google Scholar
|
|
28
|
Grove M, Demyanenko G, Echarri A, et al:
ABI2-deficient mice exhibit defective cell migration, aberrant
dendritic spine morphogenesis, and deficits in learning and memory.
Mol Cell Biol. 24:10905–10922. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dai Z and Pendergast AM: Abi-2, a novel
SH3-containing protein interacts with the c-Abl tyrosine kinase and
modulates c-Abl transforming activity. Genes Dev. 9:2569–2582.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kulkarni SK and Patil CS:
Phosphodiesterase 5 enzyme and its inhibitors: update on
pharmacological and therapeutical aspects. Methods Find Exp Clin
Pharmacol. 26:789–799. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lynch MJ, Baillie GS and Houslay MD:
cAMP-specific phosphodiesterase-4D5 (PDE4D5) provides a paradigm
for understanding the unique non-redundant roles that PDE4 isoforms
play in shaping compartmentalized cAMP cell signalling. Biochem Soc
Trans. 35:938–941. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ishizuka Y, Nakayama K, Ogawa A, et al:
TRIB1 downregulates hepatic lipogenesis and glycogenesis via
multiple molecular interactions. J Mol Endocrinol. 52:145–158.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Angyal A and Kiss-Toth E: The tribbles
gene family and lipoprotein metabolism. Curr Opin Lipidol.
23:122–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dugast E, Kiss-Toth E, Soulillou JP,
Brouard S and Ashton-Chess J: The Tribbles-1 protein in humans:
roles and functions in health and disease. Curr Mol Med. 13:80–85.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vacaru AM, Tafesse FG, Ternes P, et al:
Sphingomyelin synthase-related protein SMSr controls ceramide
homeostasis in the ER. J Cell Biol. 185:1013–1027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu J, Zhang H, Li Z, et al: Sphingomyelin
synthase 2 is one of the determinants for plasma and liver
sphingomyelin levels in mice. Arterioscler Thromb Vasc Biol.
29:850–856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Separovic D, Hanada K, Awad Maitah MIY, et
al: Sphingomyelin synthase 1 suppresses ceramide production and
apoptosis post-photodamage. Biochem Biophys Res Commun.
358:196–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ruiz R, Jideonwo V, Ahn M, et al: Sterol
regulatory element-binding protein-1 (SREBP-1) is required to
regulate glycogen synthesis and gluconeogenic gene expression in
mouse liver. J Biol Chem. 289:5510–5517. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Go GW and Mani A: Low-density lipoprotein
receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J
Biol Med. 85:19–28. 2012.PubMed/NCBI
|
|
40
|
Pols MS and Klumperman J: Trafficking and
function of the tetraspanin CD63. Exp Cell Res. 315:1584–1592.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Maecker HT, Todd SC and Levy S: The
tetraspanin superfamily: molecular facilitators. FASEB J.
11:428–442. 1997.PubMed/NCBI
|
|
42
|
Scott DW and Patel RP: Endothelial
heterogeneity and adhesion molecules N-glycosylation: implications
in leukocyte trafficking in inflammation. Glycobiology. 23:622–633.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Subathra M, Qureshi A and Luberto C:
Sphingomyelin synthases regulate protein trafficking and secretion.
PLoS One. 6:e236442011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kapustin A, Stepanova V, Aniol N, et al:
Fibulin-5 binds urokinase-type plasminogen activator and mediates
urokinase-stimulated β1-integrin-dependent cell migration. Biochem
J. 443:491–503. 2012.PubMed/NCBI
|
|
45
|
Choi J, Bergdahl A, Zheng Q, Starcher B,
Yanagisawa H and Davis EC: Analysis of dermal elastic fibers in the
absence of fibulin-5 reveals potential roles for fibulin-5 in
elastic fiber assembly. Matrix Biol. 28:211–220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Declerck PJ and Gils A: Three decades of
research on plasminogen activator inhibitor-1: a multifaceted
serpin. Semin Thromb Hemost. 39:356–364. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Satoh T, Kidoya H, Naito H, et al:
Critical role of Trib1 in differentiation of tissue-resident
M2-like macrophages. Nature. 495:524–528. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dugast E, Kiss-Toth E, Docherty L, et al:
Identification of Tribbles-1 as a novel binding partner of Foxp3 in
regulatory T cells. J Biol Chem. 288:10051–10060. 2013. View Article : Google Scholar : PubMed/NCBI
|
